Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: Distribution, serotypes, and resistance levels

Pediatric Infectious Disease Journal

Volumn 31, Issue 2, 2012, Pages 154-158

  Couloigner, Vincent ^a   Levy, Corinne ^b   François, Martine ^c   Bidet, Philippe ^d   Hausdorff, William P ^e   Pascal, Thierry ^e   Boucherat, Michel ^b   Bingen, Edouard ^d   Mariani, Patricia ^d   Pierrot, Sébastien ^a   Bille, Emmanuelle ^a   Carbonnelle, Etienne ^a   Varon, Emmanuelle ^f   Cohen, Robert ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b ACTIV Association Clinique et Thérapeutique Infantile du Val de Marne   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Conjugate vaccine; Epidemiology; Otitis media; Streptococcus pneumoniae

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; PENICILLIN G; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ACUTE OTITIS MEDIA; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CHILD; FEMALE; FRANCE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; PNEUMOCOCCAL INFECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; RECURRENT DISEASE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; FRANCE; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

EID: 84858159066     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182357c8d     Document Type: Article

References (46)

1. Wolleswinkel-van den Bosch JH, Stolk EA, Francois M, et al. The health care burden and societal impact of acute otitis media in seven European countries: results of an Internet survey. Vaccine. 2010;28(suppl 6):G39-G52.
2. Daly KA, Hoffman HJ, Kvaerner KJ, et al. Epidemiology, natural history, and risk factors: panel report from the Ninth International Research Conference on Otitis Media. Int J Pediatr Otorhinolaryngol. 2010;74:231-240.
3. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364:105-115.
4. Vergison A, Dagan R, Arguedas A, et al. Otitis media and its consequences: beyond the earache. Lancet Infect Dis. 2010;10:195-203.
5. Levy C, Thollot F, Corrard F, et al. Acute otitis media in ambulatory practice: epidemiological and clinical characteristics after 7 valent pneumococcal conjugate vaccine (PCV7) implementation [in French]. Arch Pediatr. 2011;18:712-718.
6. Greenberg D, Hoffman S, Leibovitz E, et al. Acute otitis media in children: association with day care centers - antibacterial resistance, treatment, and prevention. Paediatr Drugs. 2008;10:75-83. (Pubitemid 351414755)
7. Gaudelus J, Cohen R, Hovart J. Evolution of PCV7 coverage in 2006 to 2008: analysis of health records. Medecine et Enfance. 2009:151-154.
8. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409. (Pubitemid 32128672)
9. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22:10-16. (Pubitemid 36091771)
10. Zhou F, Shefer A, Kong Y, et al. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. 2008;121:253-260. (Pubitemid 351198446)
11. Taylor S, Suaya J, Suppapanya N, et al. Eleven-year trend of otitis media among children aged <2 years in the United States, 1997-2007. In: the European Society for Paediatric Infectious Diseases; 2010; (Nice):France. Abstract 618.
12. Pichichero ME, Casey JR, Hoberman A, et al. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr (Phila). 2008;47:901-906.
13. McEllistrem MC, Adams J, Mason EO, et al. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003;188:1679 -1684.
14. Mahjoub-Messai F, Doit C, Mariani-Kurkdjian P, et al. Epidemiology of acute otitis media caused by Streptococcus pneumoniae: emergence of serotype 19A [in French]. Arch Pediatr. 2008;15:1713-1716.
15. Dupont D, Mahjoub-Messai F, Francois M, et al. Evolving microbiology of complicated acute otitis media before and after introduction of the pneumococcal conjugate vaccine in France. Diagn Microbiol Infect Dis. 2010;68:89-92.
16. Cohen R, de la Rocque F, Boucherat M, et al. Treatment failure in otitis media: an analysis. J Chemother. 1994;6(suppl 4):17-22; discussion 23-24.
17. Leibovitz E, Raiz S, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J. 1998;17:463-469. (Pubitemid 28287609)
18. Hausdorff WP, Yothers G, Dagan R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002;21:1008 -1016.
19. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829-833. (Pubitemid 40221025)
20. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23:824-828. (Pubitemid 40221024)
21. McEllistrem MC, Adams JM, Patel K, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005;40:1738 -1744.
22. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29:304 -309.
23. AFSSAPS. Antibiotic therapy in current practice in upper respiratory tract infections in adults and children. Recommendations. Available at: www.afssaps.sante.fr. 2005.
24. Bingen E, Cohen R, Jourenkova N, et al. Epidemiologic study of conjunctivitis-otitis syndrome. Pediatr Infect Dis J. 2005;24:731-732. (Pubitemid 41140960)
25. Watts JL, Shryock TR, Apley M, et al. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
26. Norskov-Lauritsen N, Ridderberg W, Erikstrup LT, et al. Evaluation of disk diffusion methods to detect low-level beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. APMIS. 2011;119:385-392.
27. Carvalho Mda G, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45:2460-2466. (Pubitemid 47295474)
28. Prymula R, Kriz P, Kaliskova E, et al. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzaederived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine. 2009;28:71-78.
29. Kouchner B. National plan to promote prudent antibiotic use. Available at: http://wwwsantegouvfr/htm/actu/antibio/indexhtm. 2001.
30. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev. 2007;20:368 -389.
31. Cohen R, Levy C, Bonnet E, et al. Streptococcus pneumoniae, Haemophilus influenzae, Branhamella catarrhalis and Staphylococcus aureus nasopharyngeal carriage in children before and after pneumococcal conjugate vaccine implementation. In: Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2010. Oral presentation 1285.
32. Cohen R, Bingen E, Levy C, et al. Antibiotic resistance of pneumococci and H. influenzae isolated from the nasopharyngeal flora of children with acute otitis media between 2006 and 2010 [in French]. Arch Pediatr. 2011;18:926-931.
33. Cohen R, Levy C, Bonnet E, et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine. 2010;28:6114-6121.
34. Cohen R, Levy C, Bonnet E, et al. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis. 2011;11:95.
35. Mahjoub-Messai F, Doit C, Koeck JL, et al. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal vaccination for French children. J Clin Microbiol. 2009;47:837- 840.
36. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298:1772-1778. (Pubitemid 47598445)
37. Levy C, Varon E, Bingen E, et al. Pneumococcal meningitis in French children before and after the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2011;30:168-170.
38. Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26:468-472. (Pubitemid 46847304)
39. Brook I. Use of oral cephalosporins in the treatment of acute otitis media in children. Int J Antimicrob Agents. 2004;24:18 -23.
40. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-259. (Pubitemid 26098477)
41. Dabernat H, Avril JL, Boussougant Y. In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infections. J Antimicrob Chemother. 1990;26(suppl E):1-6.
42. Varon E, Levy C, De La Rocque F, et al. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin Infect Dis. 2000;31:477-481. (Pubitemid 32289579)
43. Barkai G, Leibovitz E, Givon-Lavi N, et al. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J. 2009;28:466-471.
44. Dagan R, Schneider S, Givon-Lavi N, et al. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children. Pediatr Infect Dis J. 2008;27:200-206.
45. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J. 2004;23:1142-1152.
46. Rodgers GL, Arguedas A, Cohen R, et al. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine. 2009;27:3802-3810.